An Abortion Loophole Even With a Pro-Life Supreme Court Win? The Shocking New Study Amid the Abortion Pill Battle
As the U.S. Food and Drug Administration prepares to issue a decision on the handling of chemical abortion safeguards, the author of a new study is sounding the alarm over reported dangers posed by the abortion pill.
Dr. James Studnicki, vice president of data analytics at the The Charlotte Lozier Institute, said these pills present a potential public health crisis, especially as the FDA weighs whether to continue requiring women to receive these pills in person.
Go inside the debate on this episode of "Edifi With Billy Hallowell."
As the U.S. Food and Drug Administration prepares to issue a decision on the handling of chemical abortion safeguards, the author of a new study is sounding the alarm over reported dangers posed by the abortion pill.
Dr. James Studnicki, vice president of data analytics at the The Charlotte Lozier Institute, said these pills present a potential public health crisis, especially as the FDA weighs whether to continue requiring women to receive these pills in person.
Go inside the debate on this episode of "Edifi With Billy Hallowell."
